Statistics
Publications
16
Citations
2.9K
H-Index
13
Active since
2017
Rohit Thummalapalli is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.
Publications per year
2017–2024
16
16
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco et al. · Cell · 2018 · 1.4K citations · Full text
Medicine, Cancer Biology, Oncology +12
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 585 citations
Medicine, Immunology, Oncology +17
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
Israel Cañadas, Rohit Thummalapalli, Jong Wook Kim et al. · Nature Medicine · 2018 · 317 citations · Full text
Life Sciences, Immunology, Oncology +14
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
Tyler E. Miller, Brian B. Liau, Lisa C. Wallace et al. · Nature · 2017 · 206 citations · Full text
Medicine, Cancer Biology, Oncology +12
Alveolar Differentiation Drives Resistance to <i>KRAS</i> Inhibition in Lung Adenocarcinoma
Zhuxuan Li, Xueqian Zhuang, Chun‐Hao Pan et al. · Cancer Discovery · 2023 · 66 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 16